P.W. Finn (Chicago, United States of America), M. Lommatzsch (Rostock, Germany), G. Ttrudeke Moller (Leiden, Netherlands), T. Mauad (Sao Paulo, Brazil)
Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks
A. Mahashur, D. Talwar, R. Guleria, M. Kotnis (Mumbai, Noida, Delhi, India)
|   |
Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study
H. Inoue, G. Tsukuya, S. Fukuyama, Y. Nakanishi, T. Samukawa, T. Nakamura, K. Matsumoto (Kagoshima, Fukuoka, Tokyo, Japan)
| |
The VCD-5: A short questionnaire for the diagnosis of vocal cord dysfunction
A. Thurston, J. Haines, B. Chesworth, S. Lillie, S. J. Fowler (Preston, Manchester, United Kingdom)
| |
House dust mites’ sublingual immunotherapy for respiratory allergies in clinical practice (ACTIVE)
F. De Blay, B. Delaisi, Y. Jeanpetit, D. Ebbo, Y. P. Massabie, M. Migueres (Strasbourg, Boulogne Billancourt, Antony, Issy les Moulineaux, Marseille, Saint Jean, France)
| |
Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
R. K. Zeldin, Y. Amistani, J. Cognet-Sicé, K. Abiteboul (Antony, France)
| |
Factors influencing to HRQOL of patients with mild to moderate persistent asthma in Japan; sub-analysis of GAIA study
K. Sugiyama, T. Fukuda, M. Adachi, K. Ohta, Y. Tohda, S. Shoji, T. Miyamoto (Mibu, Tokyo, Kiyose, Osakasayama, Japan)
| |
Evaluation of systemic exposure between two nasal spray formulations of mometasone furoate in healthy subjects
M. Phatak, S. Chachad, S. Purandare, G. Malhotra, K. Gandhi (Mumbai, India)
| |
Restriction of physical activity in asthmatic children and adolescents by their relatives
M. Valois, F. Assis, E. Costa, S. Sarinho, E. Sarinho, A. Rizzo (Petrolina, Recife, Maceió, Brazil)
| |
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
M. Barthwal, V. Dutta, P. Bhattacharya, A. Vora, M. Kotnis (Indore, Chandigarh, Kolkotta, Mumbai, India)
| |
Existence of “IgG4-related pleuritis” and its clinical features
A. Tanaka, K. Kurasawa, M. Tatewaki, J. Nagasawa, S. Arai, T. Owada, R. Maezawa, F. Fukushima, T. Fukuda (Mibu, Tochigi, Japan)
| |
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
F. Özseker, I. Bulut, F. Erdenen, A. Gelincik, D. Erdogdu, R. Ersoy, A. Kutlu, F. Talay, B. çolakoglu, S. Büyüköztürk (Istanbul, Istanbull, Bolu, Turkey)
| |
Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience
S. Jain, D. Saralaya, K. Regan, L. Walker (Bradford, United Kingdom)
| |
Expiratory vocal cord dysfunction - symptom presentation and co-morbidities
S. Lillie, S. Fowler (Preston, United Kingdom)
| |
Asthma affects time to pregnancy and fertility - A register based twin study
E. Juul Gade, S. Franscis Thomsen, S. Lindenberg, K. Ohm Kyvik, S. Lieberoth, V. Backer (Copenhagen, Odense, Denmark)
| |
The effect of SLIT on asthma symptoms at different pediatric age ranges
F. Occasi, G. De Castro, G. Castagna, T. Melengu, A. di Coste, P. Pansa, M. Duse (Rome, Italy)
| |
The evaluation of asthma control after the March 11, 2011 complex disaster of earthquake, tsunami, and nuclear power plant accident
A. Fukuhara, S. Sato, M. Uematsu, K. Misa, T. Nikaido, N. Fukuhara, X. Wang, K. Kanazawa, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan)
| |
Combined therapy of asthma and allergic rhinitis
N. Zhukova, M. Zakharova, O. Kryuchkova (Simferopol, Ukraine)
| |
The association between clinical features of asthma and impact of one-year sublingual immunotherapy on immunological system of atopic children
O. Ciepiela, A. Zawadzka-Krajewska, I. Kotula, U. Demkow (Warsaw, Poland)
| |
Prevalence of asthma and allergies and family’s education grade in Japan
H. Odajima, Y. Amimoto, Y. Murakami, C. Motomura (Fukuoka, Japan)
| |
Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
F. Yangui, M. Abouda, M. Triki, S. Sellami, A. Hedhli, H. Khouani, M. R. Charfi (La Marsa, Tunisia)
| |